0001209191-23-053691.txt : 20231026 0001209191-23-053691.hdr.sgml : 20231026 20231026173416 ACCESSION NUMBER: 0001209191-23-053691 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231024 FILED AS OF DATE: 20231026 DATE AS OF CHANGE: 20231026 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kulkarni Sandeep Chidambar CENTRAL INDEX KEY: 0001945691 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40384 FILM NUMBER: 231351280 MAIL ADDRESS: STREET 1: 92 MORNINGSIDE AVE. STREET 2: APT 7E CITY: NEW YORK STATE: NM ZIP: 10027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tourmaline Bio, Inc. CENTRAL INDEX KEY: 0001827506 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 27 WEST 24TH STREET STREET 2: SUITE 702 CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 646-481-9832 MAIL ADDRESS: STREET 1: 27 WEST 24TH STREET STREET 2: SUITE 702 CITY: NEW YORK STATE: NY ZIP: 10010 FORMER COMPANY: FORMER CONFORMED NAME: Talaris Therapeutics, Inc. DATE OF NAME CHANGE: 20201007 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-10-24 0 0001827506 Tourmaline Bio, Inc. TRML 0001945691 Kulkarni Sandeep Chidambar C/O TOURMALINE BIO, INC. 27 WEST 24TH STREET, SUITE 702 NEW YORK NY 10010 1 1 0 0 CEO 0 Common Stock 2023-10-24 4 P 0 4650 10.68 A 720735 D Common Stock 2023-10-26 4 P 0 5000 12.25 A 725735 D /s/ Brad Middlekauff, Attorney-in-Fact 2023-10-26